Study of Nitazoxanide in the Treatment of Chronic Hepatitis C
Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide in the Treatment of Chronic Hepatitis C
Sponsor: Romark Laboratories L.C.
A PHASE2 clinical study on Chronic Hepatitis C, this trial is completed. The trial is conducted by Romark Laboratories L.C. and has accumulated 4 data snapshots since 2005. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2017 — Jan 2021 [monthly]
Completed PHASE2
First recorded
Feb 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Romark Laboratories L.C.
For direct contact, visit the study record on ClinicalTrials.gov .